FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
This Quarter Return
+33.49%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$22.3B
AUM Growth
+$22.3B
(+27%)
Cap. Flow
+$218M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
486
New
68
Increased
146
Reduced
193
Closed
54
Top Buys
| 1 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$244M |
| 2 |
Vistra
VST
|
$228M |
| 3 |
Roblox
RBLX
|
$149M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$147M |
| 5 |
Constellation Energy
CEG
|
$134M |
Top Sells
| 1 |
Applovin
APP
|
$177M |
| 2 |
NRG Energy
NRG
|
$173M |
| 3 |
Netflix
NFLX
|
$150M |
| 4 |
Core Scientific
CORZ
|
$97.9M |
| 5 |
Broadcom
AVGO
|
$90.3M |
Sector Composition
| 1 | Technology | 34.53% |
| 2 | Communication Services | 19.7% |
| 3 | Consumer Discretionary | 14.06% |
| 4 | Industrials | 10.3% |
| 5 | Healthcare | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
376
Niagen Bioscience, Inc. Common Stock
NAGE
$771M
| $662K | ﹤0.01% |
+45,923
| New | +$662K |
|
377
Ascendis Pharma
ASND
$12.1B
| $655K | ﹤0.01% |
3,795
-61,011
| -94% | -$10.5M |
|
378
Alkermes
ALKS
$4.95B
| $648K | ﹤0.01% |
22,648
-14,863
| -40% | -$425K |
|
379
Procept Biorobotics
PRCT
$2.11B
| $638K | ﹤0.01% |
+11,081
| New | +$638K |
|
380
Vaxcyte
PCVX
$4.17B
| $594K | ﹤0.01% |
18,271
-4,089
| -18% | -$133K |
|
|
CBLL
381
CeriBell, Inc. Common Stock
CBLL
$426M
| $539K | ﹤0.01% |
28,791
-29
| -0.1% | -$543 |
|
382
Veralto
VLTO
$26.1B
| $527K | ﹤0.01% |
5,211
-399
| -7% | -$40.3K |
|
383
IBM
IBM
$227B
| $487K | ﹤0.01% |
+1,653
| New | +$487K |
|
384
Ecolab
ECL
$77.5B
| $486K | ﹤0.01% |
1,799
-330
| -16% | -$89.1K |
|
385
Xylem
XYL
$34B
| $475K | ﹤0.01% |
3,671
| – | – |
|
|
ATYR
386
aTyr Pharma
ATYR
$560M
| $469K | ﹤0.01% |
+92,493
| New | +$469K |
|
387
Agilent Technologies
A
$35.5B
| $452K | ﹤0.01% |
+3,830
| New | +$452K |
|
388
Intercontinental Exchange
ICE
$100B
| $427K | ﹤0.01% |
2,330
+38
| +2% | +$6.97K |
|
389
Global E Online
GLBE
$5.69B
| $416K | ﹤0.01% |
12,414
-1,683,241
| -99% | -$56.5M |
|
390
Tetra Tech
TTEK
$9.45B
| $415K | ﹤0.01% |
+11,552
| New | +$415K |
|
391
Trimble
TRMB
$18.7B
| $404K | ﹤0.01% |
5,317
-604
| -10% | -$45.9K |
|
392
NewAmsterdam Pharma
NAMS
$2.8B
| $399K | ﹤0.01% |
22,037
-5,384
| -20% | -$97.5K |
|
393
First Solar
FSLR
$21.6B
| $396K | ﹤0.01% |
2,395
-206
| -8% | -$34.1K |
|
394
Ionis Pharmaceuticals
IONS
$9.64B
| $374K | ﹤0.01% |
+9,464
| New | +$374K |
|
395
Camtek
CAMT
$3.51B
| $337K | ﹤0.01% |
3,989
-3,740
| -48% | -$316K |
|
396
Nextracker
NXT
$9.88B
| $327K | ﹤0.01% |
6,018
| – | – |
|
397
Trevi Therapeutics
TRVI
$871M
| $325K | ﹤0.01% |
59,425
-17,274
| -23% | -$94.5K |
|
398
Bank of America
BAC
$371B
| $309K | ﹤0.01% |
6,538
-88,084
| -93% | -$4.17M |
|
|
PVLA
399
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $305K | ﹤0.01% |
+13,542
| New | +$305K |
|
400
Electronic Arts
EA
$42B
| $270K | ﹤0.01% |
1,689
-242
| -13% | -$38.6K |
|